Anuh Pharma Limited
Anuh Pharma Limited is an Indian listed company in the Pharmaceuticals & Biotechnology industry (Healthcare sector), traded under NSE: ANUHPHR and BSE: 506260 (ISIN INE489G01022).
It has a market capitalisation of ₹830 crore, a last close of ₹82.79 on 2026-10-19, a one-year return of 4.3%.
Valuation: a price-to-earnings ratio of 18.79x, a price-to-book ratio of 2.36x, a dividend yield of 1.8%.
Profitability: return on equity of 12.1%, return on capital employed of 16.0%, an operating margin of 8.3%.
Growth: sales growth of 13.5% a year over three years, net profit growth of 4.3% a year over three years.
Balance sheet and ownership: debt-to-equity of 0.00x, promoter holding of 71.8%.
| Metric | Value |
|---|---|
| Market capitalisation | 830 |
| Last close | ₹82.79 |
| P/E (TTM) | 18.79x |
| P/B | 2.36x |
| Dividend yield | 1.8% |
| ROE (FY) | 12.1% |
| ROCE (FY) | 16.0% |
| Operating margin (TTM) | 8.3% |
| Sales growth, 3-year CAGR | 13.5% |
| Profit growth, 3-year CAGR | 4.3% |
| Debt / equity | 0.00x |
| Promoter holding | 71.8% |
| 1-year return | 4.3% |
Loading the live page with the price chart, financial history, shareholding and recent filings. Data is end-of-day and rebuilt nightly; nothing here is investment advice. Financial statements · What each metric means